prazosin has been researched along with Urinary Tract Diseases in 6 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We determined the efficacy and safety of a relatively high dose of terazosin (5mg) in Korean patients with lower urinary tract symptoms (LUTS), with or without concomitant hypertension." | 9.12 | High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study. ( Ku, JH; Kwak, C; Lee, JK, 2007) |
| "We determined the efficacy and safety of a relatively high dose of terazosin (5mg) in Korean patients with lower urinary tract symptoms (LUTS), with or without concomitant hypertension." | 5.12 | High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study. ( Ku, JH; Kwak, C; Lee, JK, 2007) |
| "dizziness and orthostatic hypotension)." | 2.40 | A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. ( Djavan, B; Marberger, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linsenmeyer, TA | 1 |
| Horton, J | 1 |
| Benevento, J | 1 |
| Kwak, C | 1 |
| Lee, JK | 1 |
| Ku, JH | 1 |
| Djavan, B | 1 |
| Marberger, M | 1 |
| Blanchard, K | 1 |
| Hananel, A | 1 |
| Rutchik, S | 1 |
| Sullivan, J | 1 |
| Bennett, JK | 1 |
| Foote, J | 1 |
| El-Leithy, TR | 1 |
| Saleem, MD | 1 |
| Green, B | 1 |
| Archer, CL | 1 |
| Gray, M | 1 |
| Wein, AJ | 1 |
2 reviews available for prazosin and Urinary Tract Diseases
| Article | Year |
|---|---|
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizzines | 1999 |
Pharmacologic treatment of lower urinary tract dysfunction in the female patient.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents, Tricyclic; Bethanechol; Bethanechol Co | 1985 |
1 trial available for prazosin and Urinary Tract Diseases
| Article | Year |
|---|---|
High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or without concomitant hypertension: a prospective, open-label study.
Topics: Adrenergic alpha-Antagonists; Aged; Asian People; Blood Pressure; Humans; Hypertension; Korea; Male; | 2007 |
3 other studies available for prazosin and Urinary Tract Diseases
| Article | Year |
|---|---|
Impact of alpha1-blockers in men with spinal cord injury and upper tract stasis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Humans; Male; Prazosin | 2002 |
Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
Topics: Adrenergic alpha-Antagonists; Aged; Comorbidity; Doxazosin; Humans; Louisiana; Male; Postoperative C | 2000 |
Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patients.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Ataxia; Humans; Male; Middle Aged; Prazosin; | 2000 |